Impetus Digital

AUGUST 2, 2024

Looking back at 2023 , AI for drug discovery saw both wins and losses. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

European Pharmaceutical Review

OCTOBER 27, 2022

Ahead of the world’s largest pharma event, CPHI Frankfurt – hosted at the Frankfurt Messe (1-3 November, 2022) – part i of the CPHI Annual Report looks ahead at the opportunities for biologics outsourcing and contract manufacturing organisastions (CMOs) in 2023. percent in 2022. In the report some 50.4 percent in 2021).

Biopharma 98

Biopharma Manufacturing Pharmacology Training 98

European Pharmaceutical Review

JANUARY 11, 2024

There is a clear trend away from developing pharmacological therapies targeting opioid receptors” There is a clear trend away from developing pharmacological therapies targeting opioid receptors. Towards the end of 2023, one sensed an emerging interest from Big Pharma in neuroscience. References Cruccu G, Truini A.

Medicine 102

Medicine Pharmacology Management Side effects 102

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 85

FDA Healthcare Healthcare Medicine 85

European Pharmaceutical Review

JANUARY 18, 2024

billion by 2023, driven by the launch of Merck’s Belsomra and Eisai’s lemborexant (E-2006). GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. billion across the 7MM up to 2032, GlobalData’s predicted in a report published in December 2023.

Marketing 98

Marketing Sales Pharmacology Pharma 98

pharmaphorum

NOVEMBER 1, 2022

Date: 8 – 9 February 2023. In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. Director, Clinical Pharmacology. LinkedIn: SAE Media Group Pharma. 14th Annual RNA Therapeutics.

Medicine 52

Medicine Pharmacology Networking Pharma 52

Clarivate

SEPTEMBER 11, 2024

Timely and accurate diagnosis is critical to maximize the efficacy of available interventions – but for most individuals, the diagnostic journey remains long, complex and costly (Alzheimer’s Disease International, 2021; Chiari, 2022; Juganavar, 2023). Food and Drug Administration, 2023 and 2024). 2024; Quanterix, 2024). Emblad, S.

Food and Drug Administration 59

Food and Drug Administration Pharmacology Food FDA 59